Non-cell-autonomous Neurotoxicity of α-synuclein Through Microglial Toll-like Receptor 2

Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity

Polazzi, E., Mengoni, I., Caprini, M., Peña‐Altamira, E., Kurtys, E., & Monti, B. (2012) · Neurosignals · doi:10.1159/000337115 · Cited by 9,023 · see citing works

ATP mediates rapid microglial response to local brain injury in vivo

Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., Littman, D. R., Dustin, M. L., & Gan, W.-B. (2005) · Nature Neuroscience · doi:10.1038/nn1472 · Cited by 3,913 · see citing works

Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components.

Takeuchi, O., Hoshino, K., Kawai, T., Sanjo, H., Takada, H., Ogawa, T., Takeda, K., & Akira, S. (1999) · Immunity · doi:10.1016/s1074-7613(00)80119-3 · Cited by 3,680 · see citing works

Microglia: Active sensor and versatile effector cells in the normal and pathologic brain

Hanisch, U.-K., & Kettenmann, H. (2007) · Nature Neuroscience · doi:10.1038/nn1997 · Cited by 3,676 · see citing works

The many faces of α-synuclein: from structure and toxicity to therapeutic target

Lashuel, H. A., Overk, C., Oueslati, A., & Masliah, E. (2012) · Nature reviews. Neuroscience · doi:10.1038/nrn3406 · Cited by 1,623 · see citing works

Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism

Block, M. L., & Hong, J.-S. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.06.004 · Cited by 1,557 · see citing works

Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein

Desplats, P., Lee, H.-J., Bae, E.-J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E., & Lee, S.-J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903691106 · Cited by 1,485 · see citing works

Direct Transfer of α-Synuclein from Neuron to Astroglia Causes Inflammatory Responses in Synucleinopathies

Lee, H.-J., Suk, J.-E., Patrick, C., Bae, E.-J., Cho, J.-H., Rho, S., Hwang, D., Masliah, E., & Lee, S.-J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.081125 · Cited by 877 · see citing works

Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia

Kim, C., Ho, D.-H., Suk, J.-E., You, S., Michael, S., Kang, J., Joong Lee, S., Masliah, E., Hwang, D., Lee, H.-J., et al. (2013) · Nature Communications · doi:10.1038/ncomms2534 · Cited by 856 · see citing works

Intravesicular Localization and Exocytosis of α-Synuclein and its Aggregates

Lee, H.-J., Patel, S. S., & Lee, S. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0692-05.2005 · Cited by 798 · see citing works

Toll-like receptor signaling in neural plasticity and disease

Okun, E., Griffioen, K. J. S., & Mattson, M. P. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.02.005 · Cited by 513 · see citing works

Microglia: actively surveying and shaping neuronal circuit structure and function

Wake, H., Moorhouse, A. J., Miyamoto, A., & Nabekura, J. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2012.11.007 · Cited by 448 · see citing works

α-Synuclein and neuronal cell death

Cookson, M. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-9 · Cited by 420 · see citing works

α-Synucleinopathy phenotypes

McCann, H., Stevens, C. H., Cartwright, H., & Halliday, G. M. (2014) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(13)70017-8 · Cited by 364 · see citing works

Blocking Soluble Tumor Necrosis Factor Signaling with Dominant-Negative Tumor Necrosis Factor Inhibitor Attenuates Loss of Dopaminergic Neurons in Models of Parkinson's Disease

McCoy, M. K., Martinez, T. N., Ruhn, K. A., Szymkowski, D. E., Smith, C. G., Botterman, B. R., Tansey, K. E., & Tansey, M. G. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1504-06.2006 · Cited by 355 · see citing works

Heat‐shock protein 70 modulates toxic extracellular α‐synuclein oligomers and rescues trans‐synaptic toxicity

Danzer, K. M., Ruf, W. P., Putcha, P., Joyner, D., Hashimoto, T., Glabe, C. C., Hyman, B. T., & McLean, P. J. (2010) · The FASEB Journal · doi:10.1096/fj.10-164624 · Cited by 309 · see citing works

The influence of microglia on the pathogenesis of Parkinson's disease

Long-Smith, C. M., Sullivan, A. M., & Nolan, Y. M. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.08.001 · Cited by 296 · see citing works

Non‐classical exocytosis of α‐synuclein is sensitive to folding states and promoted under stress conditions

Jang, A., Lee, H., Suk, J., Jung, J., Kim, K., & Lee, S. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06695.x · Cited by 281 · see citing works

Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson’s disease patients

Doorn, K. J., Moors, T., Drukarch, B., van de Berg, W. D., Lucassen, P. J., & van Dam, A.-M. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0090-1 · Cited by 254 · see citing works

Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1β in the substantia nigra

Ferrari, C. C., Pott Godoy, M. C., Tarelli, R., Chertoff, M., Depino, A. M., & Pitossi, F. J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.06.013 · Cited by 235 · see citing works

Screening of innate immune receptors in neurodegenerative diseases: A similar pattern

Letiembre, M., Liu, Y., Walter, S., Hao, W., Pfander, T., Wrede, A., Schulz-Schaeffer, W., & Fassbender, K. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.08.018 · Cited by 228 · see citing works

Microglia as liaisons between the immune and central nervous systems: Functional implications for multiple sclerosis

Carson, M. J. (2002) · Glia · doi:10.1002/glia.10145 · Cited by 227 · see citing works

Brain Inflammation and Microglia: Facts and Misconceptions

Jeong, H., Ji, K., Min, K., & Joe, E.-H. (2013) · Experimental Neurobiology · doi:10.5607/en.2013.22.2.59 · Cited by 182 · see citing works

Assessment of α-Synuclein Secretion in Mouse and Human Brain Parenchyma

Emmanouilidou, E., Elenis, D., Papasilekas, T., Stranjalis, G., Gerozissis, K., Ioannou, P. C., & Vekrellis, K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022225 · Cited by 163 · see citing works

Toll-like receptor expression in the blood and brain of patients and a mouse model of Parkinson's disease

Drouin-Ouellet, J., St-Amour, I., Saint-Pierre, M., Lamontagne-Proulx, J., Kriz, J., Barker, R. A., & Cicchetti, F. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu103 · Cited by 153 · see citing works

Misfolded α-synuclein and toll-like receptors: therapeutic targets for Parkinson's disease

Béraud, D., & Maguire‐Zeiss, K. A. (2011) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(11)70008-6 · Cited by 135 · see citing works

Antagonizing Neuronal Toll-like Receptor 2 Prevents Synucleinopathy by Activating Autophagy

Kim, C., Rockenstein, E., Spencer, B., Kim, H.-K., Adame, A., Trejo, M., Stafa, K., Lee, H.-J., Lee, S.-J., & Masliah, E. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.09.044 · Cited by 135 · see citing works

Quantification of α-Synuclein in Cerebrospinal Fluid As a Biomarker Candidate: Review of the Literature and Considerations for Future Studies

Mollenhauer, B., El‐Agnaf, O. M. A., Marcus, K., Trenkwalder, C., & Schlossmacher, M. G. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.10.90 · Cited by 114 · see citing works

Preconditioning of Microglia by α-Synuclein Strongly Affects the Response Induced by Toll-like Receptor (TLR) Stimulation

Roodveldt, C., Labrador‐Garrido, A., González‐Rey, E., Lachaud, C. C., Guilliams, T., Fernández-Montesinos, R., Benitez-Rondan, A., Robledo, G., Hmadcha, A., Delgado, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079160 · Cited by 96 · see citing works

Control of Inflammatory Responses: a New Paradigm for the Treatment of Chronic Neuronal Diseases

Woo, J. H., Lee, J. H., Kim, H., Park, S. J., Joe, E.-H., & Jou, I. (2015) · Experimental Neurobiology · doi:10.5607/en.2015.24.2.95 · Cited by 44 · see citing works

ATP13A2/PARK9 Deficiency Neither Cause Lysosomal Impairment Nor Alter α-Synuclein Metabolism in SH-SY5Y Cells

Bae, E.-J., Lee, C.-S., Lee, H.-J., Kim, S., & Lee, S. (2014) · Experimental Neurobiology · doi:10.5607/en.2014.23.4.365 · Cited by 8 · see citing works

Abstracts of the 25th Annual Meeting of the American Society for Bone and Mineral Research. Minneapolis, Minnesota, USA. September 19-23, 2003.

(2003) · PubMed · Cited by 1 · see citing works

Role of neuroinflammation in neurodegeneration development

Zhang, W., Xiao, D., Mao, Q., & Xia, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01486-5 · Cited by 1,668 · see citing works

Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease

Yun, S. P., Kam, T.-I., Panicker, N., Kim, S., Oh, Y., Park, J.-S., Kwon, S.-H., Park, Y. J., Karuppagounder, S. S., Park, H., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0051-5 · Cited by 1,123 · see citing works

Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson’s disease

Rocha, E. M., Miranda, B. D., & Sanders, L. H. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.04.004 · Cited by 769 · see citing works

Neuroinflammation in the central nervous system: Symphony of glial cells

Yang, Q., & Zhou, J. (2018) · Glia · doi:10.1002/glia.23571 · Cited by 520 · see citing works

Microglia: Agents of the CNS Pro-Inflammatory Response

Rodríguez-Gómez, J. A., Kavanagh, E., Engskog-Vlachos, P., Engskog, M. K. R., Herrera, A. J., Espinosa-Oliva, A. M., Joseph, B., Hajji, N., Venero, J. L., & Burguillos, M. A. (2020) · Cells · doi:10.3390/cells9071717 · Cited by 365 · see citing works

Role of Microglia TLRs in Neurodegeneration

Fiebich, B. L., Batista, C. R. A., Saliba, S. W., Yousif, N. M., & de Oliveira, A. C. P. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00329 · Cited by 291 · see citing works

The role of Toll-like receptors and neuroinflammation in Parkinson’s disease

Heidari, A., Yazdanpanah, N., & Rezaei, N. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02496-w · Cited by 275 · see citing works

Physical Exercise Inhibits Inflammation and Microglial Activation

Mee-inta, O., Zhao, Z., & Kuo, Y. (2019) · Cells · doi:10.3390/cells8070691 · Cited by 270 · see citing works

Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson’s Disease

Li, Y., Xia, Y., Yin, S., Wan, F., Hu, J., Kou, L., Sun, Y., Wu, J., Zhou, Q., Huang, J., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.719807 · Cited by 230 · see citing works

Microglia in Parkinson's disease

Ho, M. S. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-13-9913-8_13 · Cited by 227 · see citing works

Selective targeting of the TLR2/MyD88/NF-κB pathway reduces α-synuclein spreading in vitro and in vivo

Dutta, D., Jana, M., Majumder, M., Mondal, S., Roy, A., & Pahan, K. (2021) · Nature Communications · doi:10.1038/s41467-021-25767-1 · Cited by 195 · see citing works

α-Synuclein fibrils recruit peripheral immune cells in the rat brain prior to neurodegeneration

Harms, A. S., Delic, V., Thome, A. D., Bryant, N., Liu, Z., Chandra, S., Jurkuvenaite, A., & West, A. B. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0494-9 · Cited by 181 · see citing works

Toll-like receptors and their therapeutic potential in Parkinson’s disease and α-synucleinopathies

Kouli, A., Horne, C. B., & Williams-Gray, C. H. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.06.042 · Cited by 143 · see citing works

Nano-carrier enabled drug delivery systems for nose to brain targeting for the treatment of neurodegenerative disorders

Md, S., Bhattamisra, S. K., Zeeshan, F., Shahzad, N., Mujtaba, M. A., Meka, V. S., Radhakrishnan, A. K., Kesharwani, P., Baboota, S., & Ali, J. (2017) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2017.09.022 · Cited by 138 · see citing works

Innate and adaptive immune responses in Parkinson's disease

Schonhoff, A. M., Williams, G. P., Wallen, Z. D., Standaert, D. G., & Harms, A. S. (2019) · Progress in brain research · doi:10.1016/bs.pbr.2019.10.006 · Cited by 115 · see citing works

Peripheral innate immune and bacterial signals relate to clinical heterogeneity in Parkinson’s disease

Wijeyekoon, R., Kronenberg‐Versteeg, D., Scott, K. M., Hayat, S., Kuan, W., Evans, J., Breen, D. P., Cummins, G. A., Jones, J., Clatworthy, M. R., et al. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.01.018 · Cited by 102 · see citing works

Silencing Alpha Synuclein in Mature Nigral Neurons Results in Rapid Neuroinflammation and Subsequent Toxicity

Benskey, M. J., Sellnow, R. C., Sandoval, I. M., Sortwell, C. E., Lipton, J. W., & Manfredsson, F. P. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00036 · Cited by 102 · see citing works

Integrin CD11b mediates α-synuclein-induced activation of NADPH oxidase through a Rho-dependent pathway

Hou, L., Bao, X., Zang, C., Yang, H., Sun, F., Che, Y., Wu, X., Li, S., Zhang, D., & Wang, Q. (2018) · Redox Biology · doi:10.1016/j.redox.2017.11.010 · Cited by 98 · see citing works

Lack of PINK1 alters glia innate immune responses and enhances inflammation-induced, nitric oxide-mediated neuron death

Sun, L., Shen, R., Agnihotri, S. K., Chen, Y., Huang, Z., & Büeler, H. (2018) · Scientific Reports · doi:10.1038/s41598-017-18786-w · Cited by 87 · see citing works

Peripheral inflammation exacerbates α‐synuclein toxicity and neuropathology in Parkinson's models

Vitola, P. L., Balducci, C., Baroni, M., Artioli, L., Santamaria, G., Castiglioni, M., Cerovic, M., Colombo, L., Caldinelli, L., Pollegioni, L., et al. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12644 · Cited by 89 · see citing works

Recent Advances in the Study of Bipolar/Rod-Shaped Microglia and their Roles in Neurodegeneration

Au, N. P. B., & Ma, C. H. E. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00128 · Cited by 82 · see citing works

Interaction of RAGE with α-synuclein fibrils mediates inflammatory response of microglia

Long, H., Zhang, S., Zeng, S., Tong, Y., Liu, J., Liu, C., & Li, D. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111401 · Cited by 85 · see citing works

Oligodendroglial α‐synucleinopathy‐driven neuroinflammation in multiple system atrophy

Hoffmann, A., Ettle, B., Battis, K., Reiprich, S., Schlachetzki, J. C. M., Masliah, E., Wegner, M., Kuhlmann, T., Riemenschneider, M. J., & Winkler, J. (2019) · Brain Pathology · doi:10.1111/bpa.12678 · Cited by 83 · see citing works

Proteostasis Disturbances and Inflammation in Neurodegenerative Diseases

Sonninen, T.-M., Goldsteins, G., Laham-Karam, N., Koıstınaho, J., & Lehtonen, Š. (2020) · Cells · doi:10.3390/cells9102183 · Cited by 84 · see citing works

LRRK2 mediates microglial neurotoxicity via NFATc2 in rodent models of synucleinopathies

Kim, C., Beilina, A., Smith, N., Li, Y., Kim, M., Kumaran, R., Kaganovich, A., Mamais, A., Adame, A., Iba, M., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay0399 · Cited by 79 · see citing works

CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson’s disease

Li, Y., Niu, M., Zhao, A., Kang, W., Chen, Z., Luo, N., Zhou, L., Zhu, X., Lu, L., & Liu, J. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1646-6 · Cited by 76 · see citing works

Alpha-synuclein oligomers impair memory through glial cell activation and via Toll-like receptor 2

Vitola, P. L., Balducci, C., Cerovic, M., Santamaria, G., Brandi, E., Grandi, F., Caldinelli, L., Colombo, L., Morgese, M. G., Trabace, L., et al. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.02.012 · Cited by 74 · see citing works

Role of exosomes in the pathogenesis of inflammation in Parkinson’s disease

Yang, X., Li, K., Huang, H., & Ren, H. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.335143 · Cited by 68 · see citing works

Neurodegeneration and neuroinflammation are linked, but independent of alpha‐synuclein inclusions, in a seeding/spreading mouse model of Parkinson's disease

Garcia, P., Jürgens‐Wemheuer, W., Uriarte Huarte, O., Michelucci, A., Masuch, A., Brioschi, S., Weihofen, A., Koncina, E., Coowar, D., Heurtaux, T., et al. (2022) · Glia · doi:10.1002/glia.24149 · Cited by 65 · see citing works

Toll-Like Receptor 2 Signaling and Current Approaches for Therapeutic Modulation in Synucleinopathies

Caplan, I. F., & Maguire‐Zeiss, K. A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00417 · Cited by 65 · see citing works

Rifampicin and Its Derivative Rifampicin Quinone Reduce Microglial Inflammatory Responses and Neurodegeneration Induced In Vitro by α-Synuclein Fibrillary Aggregates

Acuña, L., Hamadat, S., Corbalán, N. S., González-Lizárraga, F., dos-Santos-Pereira, M., Rocca, J., Sepúlveda Díaz, J., Del-Bel, E., Papy-García, D., Chehín, R. N., et al. (2019) · Cells · doi:10.3390/cells8080776 · Cited by 62 · see citing works

Oxidative stress and synaptic dysfunction in rodent models of Parkinson's disease

Imbriani, P., Martella, G., Bonsi, P., & Pisani, A. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105851 · Cited by 61 · see citing works

Platelet-to-lymphocyte ratio and neutrophil-tolymphocyte ratio may reflect differences in PD and MSA-P neuroinflammation patterns.

Madetko, N., Migda, B., Alster, P., Turski, P., Koziorowski, D., & Friedman, A. (2022) · Neurologia i Neurochirurgia Polska · doi:10.5603/pjnns.a2022.0014 · Cited by 51 · see citing works

Basal forebrain integrity, cholinergic innervation and cognition in idiopathic Parkinson’s disease

Crowley, S. J., Kanel, P., Roytman, S., Bohnen, N. I., & Hampstead, B. M. (2023) · Brain · doi:10.1093/brain/awad420 · Cited by 59 · see citing works

Microglial glutamate release evoked by α‐synuclein aggregates is prevented by dopamine

Pereira, M. D. S., Acuña, L., Hamadat, S., Rocca, J., González‐Lizárraga, F., Chehín, R. N., Sepulveda-Diaz, J. E., Bel, E. A. D., Raisman‐Vozari, R., & Michel, P. P. (2018) · Glia · doi:10.1002/glia.23472 · Cited by 59 · see citing works

Microglial inhibition alleviates alpha-synuclein propagation and neurodegeneration in Parkinson’s disease mouse model

Thi Lai, T., Kim, Y. E., Nguyen, L. T. N., Thi Nguyen, T., Kwak, I. H., Richter, F., Kim, Y. J., & Ma, H.-I. (2024) · npj Parkinson's Disease · doi:10.1038/s41531-024-00640-2 · Cited by 56 · see citing works

Inflamma-MicroRNAs in Alzheimer’s Disease: From Disease Pathogenesis to Therapeutic Potentials

Liang, Y., & Wang, L. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.785433 · Cited by 55 · see citing works

Increased expression of toll-like receptor 3, an anti-viral signaling molecule, and related genes in Alzheimer's disease brains

Walker, D. G., Tang, T. M., & Lue, L. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.07.016 · Cited by 51 · see citing works

The Presence of Alpha‐Synuclein in Skin from Melanoma and Patients with Parkinson's Disease

Rodríguez‐Leyva, I., Chi-Ahumada, É., Mejía, M., Castanedo-Cázares, J. P., Eng, W., Saikaly, S. K., Carrizales-Rodríguez, J., Levine, T., Norman, R. A., & Jiménez-Capdeville, M. E. (2017) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12494 · Cited by 41 · see citing works

Inflammation and Parkinson's disease pathogenesis: Mechanisms and therapeutic insight

Forloni, G., Vitola, P. L., Cerovic, M., & Balducci, C. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.11.001 · Cited by 39 · see citing works

Glial cells in Parkinson´s disease: protective or deleterious?

Domingues, A. V., Pereira, I. M., Vilaça-Faria, H., Salgado, A. J., Rodrigues, A. J., & Teixeira, F. G. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03584-x · Cited by 37 · see citing works

Alpha-Synuclein Induced Immune Cells Activation and Associated Therapy in Parkinson’s Disease

Su, R., & Zhou, T. G. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.769506 · Cited by 36 · see citing works

Does SARS-CoV-2 affect neurodegenerative disorders? TLR2, a potential receptor for SARS-CoV-2 in the CNS

Szabo, M. P., Iba, M., Nath, A., Masliah, E., & Kim, C. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00755-7 · Cited by 35 · see citing works

Bidirectional communication between mast cells and the gut-brain axis in neurodegenerative diseases: Avenues for therapeutic intervention

Bhuiyan, P., Chen, Y., Karim, M., Dong, H., & Qian, Y. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.04.010 · Cited by 33 · see citing works

The Role of Immune Dysfunction in Parkinson’s Disease Development

Cossu, D., Hatano, T., & Hattori, N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316766 · Cited by 29 · see citing works

Models of multiple system atrophy

Lee, H.-J., Ricarte, D., Ortiz, D. M., & Lee, S. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0346-8 · Cited by 30 · see citing works

Inflammation in Experimental Models of α ‐Synucleinopathies

Harms, A. S., Kordower, J. H., Sette, A., Arlehamn, C. S. L., Sulzer, D. L., & Mach, R. H. (2020) · Movement Disorders · doi:10.1002/mds.28264 · Cited by 30 · see citing works

The Role of Glial Mitochondria in α-Synuclein Toxicity

Jeon, Y., Kwon, Y., Jo, M., Lee, S., Kim, S., & Kim, H. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.548283 · Cited by 31 · see citing works

Microglia-driven inflammation induces progressive tauopathies and synucleinopathies

Lee, S. H., Bae, E.-J., Park, S. J., & Lee, S. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01450-z · Cited by 29 · see citing works

LRRK2-NFATc2 Pathway Associated with Neuroinflammation May Be a Potential Therapeutic Target for Parkinson’s Disease

Wang, Y., Zhang, X., Chen, F., Chen, L., Wang, J., & Xie, J. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s301531 · Cited by 29 · see citing works

Genetic targeting of astrocytes to combat neurodegenerative disease

Kirschen, G., Kéry, R., & Chen, A. F. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.265541 · Cited by 28 · see citing works

Precision Exercise Medicine: Sex Specific Differences in Immune and CNS Responses to Physical Activity

Cortés, C. J., & Miguel, Z. D. (2022) · Brain Plasticity · doi:10.3233/bpl-220139 · Cited by 31 · see citing works

Mixed pathology as a rule, not exception: Time to reconsider disease nosology

Chu, Y., Hirst, W. D., & Kordower, J. H. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-85538-9.00012-2 · Cited by 28 · see citing works

Model Senescent Microglia Induce Disease Related Changes in α-Synuclein Expression and Activity

Angelova, D. M., & Brown, D. R. (2018) · Biomolecules · doi:10.3390/biom8030067 · Cited by 30 · see citing works

Let’s make microglia great again in neurodegenerative disorders

Guillot‐Sestier, M., & Town, T. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1792-x · Cited by 26 · see citing works

Lysosomal storage, impaired autophagy and innate immunity in Gaucher and Parkinson's diseases: insights for drug discovery

Hull, A. J., Atilano, M. L., Gergi, L., & Kinghorn, K. J. (2024) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2022.0381 · Cited by 23 · see citing works

Systemic inflammation accelerates neurodegeneration in a rat model of Parkinson’s disease overexpressing human alpha synuclein

Cenere, M. M., Tiberi, M., Paldino, E., D’Addario, S. L., Federici, M., Giacomet, C., Cutuli, D., Matteocci, A., Cossa, F., Zarrilli, B., et al. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00824-w · Cited by 21 · see citing works

Host immune responses in the central nervous system during fungal infections

Reyes, E. Y., & Shinohara, M. L. (2022) · Immunological Reviews · doi:10.1111/imr.13101 · Cited by 22 · see citing works

Investigation of Inflammation in Lewy Body Dementia: A Systematic Scoping Review

Loveland, P. M., Yu, J. J., Churilov, L. P., Yassi, N., & Watson, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512116 · Cited by 21 · see citing works

Neuron-Glia Crosstalk Plays a Major Role in the Neurotoxic Effects of Ketamine via Extracellular Vesicles

Penning, D. H., Cazacu, S., Brodie, A., Jevtović‐Todorović, V., Kalkanis, S., Lewis, M. C., & Brodie, C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.691648 · Cited by 20 · see citing works

Non-cell autonomous modulation of tyrosine hydroxylase by HMGB1 released from astrocytes in an acute MPTP-induced Parkinsonian mouse model

Kim, S. J., Ryu, M. J., Han, J., Jang, Y., Lee, M. J., Ju, X., Ryu, I., Lee, Y. L., Oh, E., Chung, W., et al. (2019) · Laboratory Investigation · doi:10.1038/s41374-019-0254-5 · Cited by 20 · see citing works

Immunogenetic Determinants of Parkinson’s Disease Etiology

Kung, P., Elsayed, I., Reyes‐Pérez, P., & Bandrés‐Ciga, S. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223176 · Cited by 19 · see citing works

The Innate and Adaptive Immune Cells in Alzheimer’s and Parkinson’s Diseases

Huang, B., Zhenxin, Y., Chen, S., Tan, Z., Zong, Z., Zhang, H., & Xiong, X. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/1315248 · Cited by 19 · see citing works

Statistically Defined Parkinson’s Disease Executive and Memory Cognitive Phenotypes: Demographic, Behavioral, and Structural Neuroimaging Comparisons

Crowley, S., Banan, G., Amin, M., Tanner, J. J., Hizel, L., Nguyen, P., Brumback, B. A., Rodriguez, K., McFarland, N. R., Bowers, D., et al. (2020) · Journal of Parkinson's Disease · doi:10.3233/jpd-202166 · Cited by 15 · see citing works

Repositioning doxycycline for treating synucleinopathies: Evidence from a pre-clinical mouse model

Vitola, P. L., Artioli, L., Cerovic, M., Poletto, C., Dacomo, L., Leva, S., Balducci, C., & Forloni, G. (2022) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2022.105229 · Cited by 16 · see citing works

TLR4 and TLR2 activation is differentially associated with age during Parkinson’s disease

Sobrinho, H. M. D. R., da Silva, D. J., Gomides, L. F., Dorta, M. L., de Oliveira, M. A. P., & Ribeiro‐Dias, F. (2017) · Immunological Investigations · doi:10.1080/08820139.2017.1379024 · Cited by 15 · see citing works

A functional role for alpha-synuclein in neuroimmune responses

Heiden, D. L., Monogue, B., Ali, M., & Beckham, J. D. (2023) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2023.578047 · Cited by 15 · see citing works

The implication of neuronimmunoendocrine (NIE) modulatory network in the pathophysiologic process of Parkinson’s disease

Shen, Y., Guo, X., Han, C., Wan, F. J., Ma, K., Guo, S., Wang, L., Xia, Y. F., Liu, L., Lin, Z., et al. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2549-2 · Cited by 15 · see citing works

The Healing Effect of Human Milk Fat Globule-EGF Factor 8 Protein (MFG-E8) in A Rat Model of Parkinson’s Disease

Nakashima, Y., Miyagi‐Shiohira, C., Noguchi, H., & Ōmasa, T. (2018) · Brain Sciences · doi:10.3390/brainsci8090167 · Cited by 14 · see citing works

Cre‐dependent AAV vectors for highly targeted expression of disease‐related proteins and neurodegeneration in the substantia nigra

Grames, M. S., Dayton, R. D., Jackson, K. L., Richard, A. D., Lu, X., & Klein, R. L. (2018) · The FASEB Journal · doi:10.1096/fj.201701529rr · Cited by 13 · see citing works

Pathophysiology and Neuroimmune Interactions Underlying Parkinson’s Disease and Traumatic Brain Injury

Lillian, A., Zuo, W., Laham, L., Hilfiker, S., & Ye, J.-H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087186 · Cited by 12 · see citing works

NPT1220-312, a TLR2/TLR9 Small Molecule Antagonist, Inhibits Pro-Inflammatory Signaling, Cytokine Release, and NLRP3 Inflammasome Activation

Habas, A., Natala, S. R., Bowden-Verhoek, J. K., Stocking, E. M., Price, D. L., Wrasidlo, W., Bonhaus, D. W., & Gill, M. B. (2022) · International Journal of Inflammation · doi:10.1155/2022/2337363 · Cited by 12 · see citing works

Interaction between α-Synuclein and Bioactive Lipids: Neurodegeneration, Disease Biomarkers and Emerging Therapies

Sanluca, C., Spagnolo, P., Mancinelli, R., Bartolo, M. I. D., Fava, M., Maccarrone, M., Carotti, S., Gaudio, E., Leuti, A., & Vivacqua, G. (2024) · Metabolites · doi:10.3390/metabo14070352 · Cited by 9 · see citing works

Alpha-Synuclein Autoimmune Decline in Prodromal Multiple System Atrophy and Parkinson’s Disease

Folke, J., Bergholt, E., Pakkenberg, B., Aznar, S., & Brudek, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126554 · Cited by 10 · see citing works

Milk and Parkinson disease: Could galactose be the missing link

Sarni, A. R., & Baroni, L. (2018) · Mediterranean Journal of Nutrition and Metabolism · doi:10.3233/mnm-180234 · Cited by 10 · see citing works

Microglial and neuronal fates following inhibition of CSF-1R in synucleinopathy mouse model

Iba, M., Lee, Y., Horan-Portelance, L., Chang, K., Szabo, M. P., Rissman, R. A., You, S., Masliah, E., & Kim, C. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.09.016 · Cited by 8 · see citing works

Differential microglial responses to structurally distinct alpha-synuclein polymorphs

Chang, K., Kim, J., Iba, M., Park, J. H., Beilina, A., Syed, Z. A., Baena, V., Horan-Portelance, L., Cookson, M., You, S., et al. (2025) · Molecular Brain · doi:10.1186/s13041-025-01256-0 · Cited by 3 · see citing works

Long-Term Engraftment of Cryopreserved Human Neurons for In Vivo Disease Modeling in Neurodegenerative Disease

Marmion, D. J., Deng, P., Hiller, B. M., Lewis, R. L., Harms, L. J., Cameron, D. L., Nolta, J. A., Kordower, J. H., Fink, K. D., & Wakeman, D. R. (2025) · Biology · doi:10.3390/biology14020217 · Cited by 2 · see citing works

Immunity in Parkinson's disease – The role of innate responses

Iyengar, A. S., Dunkley, P. R., & Dickson, P. W. (2025) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2025.578716 · Cited by 3 · see citing works

Redirecting microglia phenotype via inhibition of NFAT1 ameliorates deficits in mouse model of synucleinopathies

Iba, M., Lee, Y., Kwon, S., Horan-Portelance, L., Chang, K., Kim, M., Landeck, N., Rissman, R. A., Lee, S. J., You, S., et al. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01564-4 · Cited by 1 · see citing works

Intranigral injection of alpha-synuclein pre-formed fibrils leads to BBB compromise and bilateral dopaminergic neurodegeneration in A53T alpha-synuclein transgenic mice

Ghosh, S., Lin, H., Chu, S., Ngu, H., Zang, N., Raman, R., Stark, K. L., Foreman, O., Hashemifar, S. S., Easton, A. E., et al. (2026) · Discover Neuroscience · doi:10.1186/s13064-026-00286-1 · Cited by 1 · see citing works

Deciphering motor dysfunction and microglial activation in mThy1-α-synuclein mice: a comprehensive study of behavioral, gene expression, and methylation changes

McGregor, B. A., Raihan, M. O., Brishti, A., Hur, J., & Porter, J. E. (2025) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2025.1544971 · Cited by 1 · see citing works

Repositioning doxycycline for treating Parkinson’s disease: Evidence from a pre‐clinical mouse model

Vitola, P. L., Artioli, L., Cerovic, M., PolettoBalducci, C., Dacomo, L., Leva, S., Balducci, C., & Forloni, G. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.056160 · Cited by 1 · see citing works

Neurodegeneration and neuroinflammation are linked, but independent of α -synuclein inclusions, in a seeding/spreading mouse model of Parkinson’s diseasePreprint

Garcia, P., Wemheuer, W. M., Huarte, O. U., Schmit, K. J., Masuch, A., Brioschi, S., Weihofen, A., Koncina, E., Coowar, D., Heurtaux, T., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.05.237750 · Cited by 1 · see citing works

Neurodegeneration and Neuroinflammation are Linked, but Independent of α-Synuclein Inclusions, in a Seeding/Spreading Mouse Model of Parkinson’s DiseasePreprint

Garcia, P., Wemheuer, W. M., Huarte, O. U., Schmit, K. J., Masuch, A., Brioschi, S., Weihofen, A., Koncina, E., Coowar, D., Heurtaux, T., et al. (2020) · doi:10.21203/rs.3.rs-29977/v1

Alpha-synuclein spreading mechanisms in Parkinson's disease: The role of membrane receptors

Brás, I. C., & Outeiro, T. F. (2021) · International review of movement disorders · doi:10.1016/bs.irmvd.2021.08.002

Orchestrating the Parkinson’s disease microenvironment in 3D for pathogenesis study and therapeutic development

Tang, X., Cui, H., & Cui, H. (2026) · Biofabrication · doi:10.1088/1758-5090/ae4895

Étude moléculaire de l'inflammation chronique dans la maladie de Parkinson

Compagnion, A. (2019) · theses.fr (ABES) · doi:10.70675/04ca138dz3131z4e24z884czbba2f7954a99

Study of the interactions between the nervous system and the gut in Parkinson’s disease using Drosophila

Yue, X. (2022) · doi:10.70675/b34b937fz70e7z48a6za103zc4073036f09e

Unconventional Protein Secretion in the Central Nervous System: Mechanisms and Roles in Physiology and Disease

Krauklis, S. A., Keceli, S. K., Campbell, E. M., & Abbineni, P. S. (2026) · Journal of Neurochemistry · doi:10.1111/jnc.70532

Parkinson's disease and immune-metabolic dysregulation

Rana, A., Thakur, A., Sharma, J., Bhandari, P., & Bisht, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44253-7.00007-2

Targeting Microglial and Neuronal Toll-like Receptor 2 in Synucleinopathies

Kwon, S., Iba, M., Masliah, E., & Kim, C. (2019) · Experimental Neurobiology · doi:10.5607/en.2019.28.5.547 · Cited by 35 · see citing works

Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation

Kim, C., Spencer, B., Rockenstein, E., Yamakado, H., Mante, M., Adame, A., Fields, J. A., Masliah, D., Iba, M., Lee, H.-J., et al. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0276-2 · Cited by 157 · see citing works

LRRK2 mediates microglial neurotoxicity via NFATc2 in rodent models of synucleinopathies

Kim, C., Beilina, A., Smith, N., Li, Y., Kim, M., Kumaran, R., Kaganovich, A., Mamais, A., Adame, A., Iba, M., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay0399 · Cited by 79 · see citing works

Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia

Kim, C., Ho, D.-H., Suk, J.-E., You, S., Michael, S., Kang, J., Joong Lee, S., Masliah, E., Hwang, D., Lee, H.-J., et al. (2013) · Nature Communications · doi:10.1038/ncomms2534 · Cited by 856 · see citing works

Activation of MyD88-dependent TLR1/2 signaling by misfolded α-synuclein, a protein linked to neurodegenerative disorders

Daniele, S. G., Béraud, D., Davenport, C., Cheng, K., Yin, H., & Maguire-Zeiss, K. A. (2015) · Science Signaling · doi:10.1126/scisignal.2005965 · Cited by 303 · see citing works